Axsome Therapeutics (AXSM) Assets: 2022-2025
Historic Assets for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to $669.2 million.
- Axsome Therapeutics' Assets rose 19.20% to $669.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $669.2 million, marking a year-over-year increase of 19.20%. This contributed to the annual value of $568.5 million for FY2024, which is 3.36% down from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Assets is $669.2 million, which was up 4.61% from $639.8 million recorded in Q2 2025.
- Axsome Therapeutics' 5-year Assets high stood at $669.2 million for Q3 2025, and its period low was $88.6 million during Q1 2022.
- For the 3-year period, Axsome Therapeutics' Assets averaged around $574.5 million, with its median value being $588.2 million (2023).
- In the last 5 years, Axsome Therapeutics' Assets spiked by 339.45% in 2023 and then decreased by 10.37% in 2024.
- Over the past 4 years, Axsome Therapeutics' Assets (Quarterly) stood at $331.5 million in 2022, then spiked by 77.46% to $588.2 million in 2023, then decreased by 3.36% to $568.5 million in 2024, then increased by 19.20% to $669.2 million in 2025.
- Its Assets stands at $669.2 million for Q3 2025, versus $639.8 million for Q2 2025 and $596.7 million for Q1 2025.